跳至主要内容
临床试验/NCT01256125
NCT01256125Unknown不适用

Therapeutic Effects of Allogene MSCs Transplantation in Patients With Chronic Liver Diseases Through Peripheral Vein.

Sun Yat-sen University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
1
主要终点
Short-term therapeutic effects at 1-8 weeks after Allogene MSCs transplantation through peripheral vein.

研究概览

简要总结

Allogene MSCs transplantation will be performed in patients with chronic liver diseases through peripheral vein and therapeutic effects including short-term effects and long-term follow-up will be compared and investigated.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
15 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • chronic liver diseases including: viral hepatitis, alcoholic liver disease, autoimmune liver disease.
  • age: 15-65 years old.

排除标准

  • pregnant women and women in lactation.
  • other systems and organs disfunction
  • space-occupying lesion were found in liver.
  • concurrent infection with HIV and other immunodeficiency diseases.
  • DIC and active bleeding were confirmed.

结局指标

主要结局

Short-term therapeutic effects at 1-8 weeks after Allogene MSCs transplantation through peripheral vein.

时间窗: 1-8 weeks after transplantation

次要结局

  • Long-term follow-up of Allogene MSCs transplantation through peripheral vein.(3-60 months)

研究者

发起方
Sun Yat-sen University
申办方类型
Other

研究点 (1)

Loading locations...

相似试验